Your browser doesn't support javascript.
loading
Pre-treatment risk factors to predict early cisplatin-related nephrotoxicity in locally advanced head and neck cancer patients treated with chemoradiation: A single Institution experience.
Cavalieri, Stefano; Platini, Francesca; Barretta, Francesco; Nuzzolese, Imperia; Ottini, Arianna; Bergamini, Cristiana; Resteghini, Carlo; Colombo, Elena; Iacovelli, Nicola Alessandro; Franceschini, Marzia; Calareso, Giuseppina; Di Pede, Patricia; De Feo, Giulia; Gandelli, Monica; Toffolatti, Luisa; Guglielmo, Mauro; Ripamonti, Carla Ida; Cosmai, Laura; Licitra, Lisa; Alfieri, Salvatore.
Affiliation
  • Cavalieri S; Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy. Electronic address: stefano.cavalieri@istitutotumori.mi.it.
  • Platini F; Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Barretta F; Department of Biostatistics for Clinical Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Nuzzolese I; Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Ottini A; Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Bergamini C; Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Resteghini C; Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Colombo E; Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Iacovelli NA; Radiotherapy Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Franceschini M; Radiotherapy Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Calareso G; Radiology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Di Pede P; Medical Oncology 4: SSD Internistic & Geriatric Supportive Care, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • De Feo G; Medical Oncology 4: SSD Internistic & Geriatric Supportive Care, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Gandelli M; Medical Oncology 4: SSD Internistic & Geriatric Supportive Care, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Toffolatti L; Medical Oncology 4: SSD Internistic & Geriatric Supportive Care, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Guglielmo M; Medical Oncology 4: SSD Internistic & Geriatric Supportive Care, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Ripamonti CI; Medical Oncology 4: SSD Internistic & Geriatric Supportive Care, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy; Università degli Studi di Brescia, Italy.
  • Cosmai L; Nephrology Unit, ASST Santi Paolo e Carlo, Milan, Italy.
  • Licitra L; Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy.
  • Alfieri S; Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Oral Oncol ; 146: 106579, 2023 11.
Article in En | MEDLINE | ID: mdl-37778228

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Acute Kidney Injury / Head and Neck Neoplasms / Antineoplastic Agents Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans / Male Language: En Journal: Oral Oncol Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Acute Kidney Injury / Head and Neck Neoplasms / Antineoplastic Agents Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans / Male Language: En Journal: Oral Oncol Year: 2023 Document type: Article